Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03247309
Title TCR-engineered T Cells in Solid Tumors With Emphasis on NSCLC and HNSCC (ACTengine) (ACTengine)
Acronym ACTengine
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immatics US, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | DEU


No variant requirements are available.